Cantel Medical (CMN) Misses Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St set for muted open as Middle East tensions curb risk appetite
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Cantel Medical Reports Results For The Second Quarter Ended January 31, 2015
March 12, 2015 8:00 AM EDTLITTLE FALLS, N.J., March 12, 2015 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMN) reported US GAAP net income of $11,085,000, or $0.27 per diluted share, inclusive of $0.04 of acquisition related (non-amortization) charges on a 14% increase in sales to $135,430,000 for the second quarter ended January 31, 2015. This compares with net income of $11,126,000 or $0.27 per diluted share, on sales of $119,042,000 for the second quarter ended January 31, 2014. For the six months ended January 31, 2015, the Company reported US GAAP net income of $22,324,000, or $0.54 per diluted share, inclusive of $0.07 of acquisition related (non-amortization) charges on a 15% increase in sales to... More
